Target intelligence / Profile preview

Circulating Anti-Double-Stranded DNA Antibody (Anti-dsDNA)

Target
Anti-dsDNA
Molecular classification
Autoantibody, Immunoglobulin
01

Overview

Circulating anti-double-stranded DNA (anti-dsDNA) antibodies are a subset of autoantibodies that specifically target double-stranded DNA, a key component of the cell nucleus. These antibodies are classified as anti-nuclear antibodies (ANA) and are most commonly associated with systemic lupus erythematosus (SLE), an autoimmune disease. Their presence in blood is highly specific for SLE and they play a significant role in both diagnosis and monitoring disease activity, especially lupus nephritis.

Other names
Anti-Double-Stranded DNA AntibodydsDNA AntibodyCirculating Anti-dsDNAAnti-dsDNA Antibodies
02

Mechanism of action

N/A - Autoantibodies are a result of disease, not a target for drugs directly.

03

Biological functions

Immune responseComplement activationImmune complex formationCellular penetration
04

Disease associations

Systemic Lupus Erythematosus (SLE)Lupus NephritisCardiovascular disease (SLE-related)Neuropsychiatric lupus
05

Safety considerations

Increased risk of infectionNephrotoxicity (related to immune complex deposition)Cardiovascular complicationsNeuropsychiatric complications
06

Interacting drugs

Belimumab

6 more in the full profile.

07

Biomarkers

Disease activity in SLELupus nephritisRisk of flaresSerum anti-dsDNA antibody titrePersistent proteinuria

Beyond the preview

Go deeper on Circulating Anti-Double-Stranded DNA Antibody (Anti-dsDNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circulating Anti-Double-Stranded DNA Antibody (Anti-dsDNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call